Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaafar Bennouna

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Bulletin Du Cancer|July 1, 2014
[Use of maintenance therapy and complete discontinuation for therapeutic management of non-resectable metastatic colorectal cancer]Hélène Senellart, Sandrine Hiret, Véronique Guerin-Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Vinflunine: a new microtubule inhibitor agentJaafar Bennouna, Jean-Pierre Delord, Mario Campone, et al.
Current Medical Research and Opinion|May 26, 2016
Oral vinorelbine plus cisplatin versus pemetrexed plus cisplatin as first-line treatment of advanced non-squamous non-small-cell lung cancer: cost minimization analysis in 12 European countriesFrancesco Grossi, Jaafar Bennouna, Libor Havel, et al.
Journal of Applied Clinical Medical Physics|October 15, 2020
Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapySuresh Rana, Jaafar Bennouna, Alonso N Gutierrez, et al.
Bulletin Du Cancer|February 26, 2018
[Metastatic colorectal cancer: To stop or not to stop?]Pascal Artru, Jaafar Bennouna, Astrid Lievre, et al.
Expert Opinion on Biological Therapy|January 19, 2020
Pembrolizumab for the treatment of colorectal cancerDahna Coupez, Pauline Hulo, Yann Touchefeu, et al.
Journal of Applied Clinical Medical Physics|July 26, 2019
Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plansSuresh Rana, Kevin Greco, E James Jebaseelan Samuel, et al.
Expert Opinion on Investigational Drugs|September 28, 2005
Vinflunine: a novel antitubulin agent in solid malignanciesJaafar Bennouna, Mario Campone, Jean Pierre Delord, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2011
Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trialJaafar Bennouna, Hélène Senellart, Sandrine Hiret, et al.
Expert Opinion on Biological Therapy|August 11, 2021
<i>KRAS</i> mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicineDahna Coupez, Pauline Hulo, Yann Touchefeu, et al.
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Bulletin Du Cancer|July 1, 2014
[Use of maintenance therapy and complete discontinuation for therapeutic management of non-resectable metastatic colorectal cancer]Hélène Senellart, Sandrine Hiret, Véronique Guerin-Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Vinflunine: a new microtubule inhibitor agentJaafar Bennouna, Jean-Pierre Delord, Mario Campone, et al.
Current Medical Research and Opinion|May 26, 2016
Oral vinorelbine plus cisplatin versus pemetrexed plus cisplatin as first-line treatment of advanced non-squamous non-small-cell lung cancer: cost minimization analysis in 12 European countriesFrancesco Grossi, Jaafar Bennouna, Libor Havel, et al.
Journal of Applied Clinical Medical Physics|October 15, 2020
Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapySuresh Rana, Jaafar Bennouna, Alonso N Gutierrez, et al.
Bulletin Du Cancer|February 26, 2018
[Metastatic colorectal cancer: To stop or not to stop?]Pascal Artru, Jaafar Bennouna, Astrid Lievre, et al.
Expert Opinion on Biological Therapy|January 19, 2020
Pembrolizumab for the treatment of colorectal cancerDahna Coupez, Pauline Hulo, Yann Touchefeu, et al.
Journal of Applied Clinical Medical Physics|July 26, 2019
Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plansSuresh Rana, Kevin Greco, E James Jebaseelan Samuel, et al.
Expert Opinion on Investigational Drugs|September 28, 2005
Vinflunine: a novel antitubulin agent in solid malignanciesJaafar Bennouna, Mario Campone, Jean Pierre Delord, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2011
Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trialJaafar Bennouna, Hélène Senellart, Sandrine Hiret, et al.
Expert Opinion on Biological Therapy|August 11, 2021
<i>KRAS</i> mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicineDahna Coupez, Pauline Hulo, Yann Touchefeu, et al.
Pageof 17